Induced human pluripotent stem cells: promises and open questions

Abstract Adult cells have been reprogrammed into induced pluripotent stem (iPS) cells by introducing pluripotency-associated transcription factors. Here, we discuss recent advances and challenges of in vitro reprogramming and future prospects of iPS cells for their use in diagnosis and cell therapy. The generation of patient-specific iPS cells for clinical application requires alternative strategies, because genome-integrating viral vectors may cause insertional mutagenesis. Moreover, when suitable iPS cell lines will be available, efficient and selective differentiation protocols are needed to generate transplantable grafts. Finally, we point to the requirement of a regulatory framework necessary for the commercial use of iPS cells.

[1]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[2]  Benoit G. Bruneau,et al.  Directed transdifferentiation of mouse mesoderm to heart tissue by defined factors , 2009, Nature.

[3]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[4]  Huck-Hui Ng,et al.  Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. , 2009, Cell stem cell.

[5]  K. Plath,et al.  Derivation of Primordial Germ Cells from Human Embryonic and Induced Pluripotent Stem Cells Is Significantly Improved by Coculture with Human Fetal Gonadal Cells , 2009, Stem cells.

[6]  Shinya Yamanaka,et al.  Broader implications of defining standards for the pluripotency of iPSCs. , 2009, Cell stem cell.

[7]  Rudolf Jaenisch,et al.  Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors , 2009, Cell.

[8]  K. Woltjen,et al.  Virus free induction of pluripotency and subsequent excision of reprogramming factors , 2009, Nature.

[9]  K. Hochedlinger,et al.  Epigenetic reprogramming and induced pluripotency , 2009, Development.

[10]  Lior Gepstein,et al.  In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. , 2009, Stem cells and development.

[11]  Marcos J. Araúzo-Bravo,et al.  Oct4-Induced Pluripotency in Adult Neural Stem Cells , 2009, Cell.

[12]  Alexander Meissner,et al.  Induced pluripotent stem cells: current progress and potential for regenerative medicine. , 2009, Trends in molecular medicine.

[13]  C. Lorson,et al.  Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.

[14]  R. Jaenisch,et al.  Reprogramming of murine and human somatic cells using a single polycistronic vector , 2009, Proceedings of the National Academy of Sciences.

[15]  D. Melton,et al.  Nuclear Reprogramming in Cells , 2008, Science.

[16]  Yi Zhang,et al.  Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts*♦ , 2008, Journal of Biological Chemistry.

[17]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[18]  J. Utikal,et al.  Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.

[19]  Sheng Ding,et al.  Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. , 2008, Cell stem cell.

[20]  Wenjun Guo,et al.  Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2 , 2008, Nature Biotechnology.

[21]  M. Rao,et al.  Regulatory Issues for Personalized Pluripotent Cells , 2008, Stem cells.

[22]  Douglas A. Melton,et al.  In vivo reprogramming of adult pancreatic exocrine cells to β-cells , 2008, Nature.

[23]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[24]  Hynek Wichterle,et al.  Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.

[25]  H. Schöler,et al.  In vitro differentiation of reprogrammed murine somatic cells into hepatic precursor cells , 2008, Biological chemistry.

[26]  Jin Woo Chang,et al.  Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells , 2008, Proceedings of the National Academy of Sciences.

[27]  A. Bang,et al.  Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo , 2008, Nature Biotechnology.

[28]  B. Heng,et al.  Induced Pluripotent Stem Cells (iPSC) – can direct delivery of transcription factors into the cytosol overcome the perils of permanent genetic modification? , 2008, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[29]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[30]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[31]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[32]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[33]  A. Nienhuis,et al.  Genotoxicity of retroviral integration in hematopoietic cells. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  T. Graf,et al.  Stepwise Reprogramming of B Cells into Macrophages , 2004, Cell.

[35]  Irving L Weissman,et al.  Plasticity of Adult Stem Cells , 2004, Cell.

[36]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[37]  Alan Colman,et al.  Cell therapy and the safety of embryonic stem cell-derived grafts. , 2007, Trends in biotechnology.